Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.
暂无分享，去创建一个
M. Dowsett | D. Dearnaley | C. Parker | J. Bono | R. A’Hern | S. Kaye | C. Messiou | D. Olmos | J. D. de Bono | G. Attard | Gloria Lee | L. R. Molife | E. Folkerd | A. Molina | T. Kheoh | A. Reid | C. Parker | N. Oommen | E. Thompson | G. Maier | R. Sinha | Christopher C. Parker